K
Ketut Suastika
Researcher at Udayana University
Publications - 88
Citations - 1120
Ketut Suastika is an academic researcher from Udayana University. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 14, co-authored 67 publications receiving 669 citations.
Papers
More filters
Journal ArticleDOI
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis.
RA Tuty Kuswardhani,Joshua Henrina,Raymond Pranata,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients and is prognostically associated with mortality and associated with a composite of poor outcomes.
Journal ArticleDOI
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis.
Raymond Pranata,Joshua Henrina,Michael Anthonius Lim,Sherly Lawrensia,Emir Yonas,Rachel Vania,Ian Huang,Antonia Anna Lukito,Ketut Suastika,RA Tuty Kuswardhani,Siti Setiati +10 more
TL;DR: In this paper, the authors performed a systematic literature search from several electronic databases up until 8 September 2020 and reported that increase in CFS was associated with increase in mortality in a linear fashion, and the potential for a nonlinear relationship based on ORs of each quantitative clinical frailty scale was examined using restricted cubic splines with a three-knots model.
Journal ArticleDOI
The DiabCare Asia 2008 study – Outcomes on control and complications of type 2 diabetic patients in Indonesia
Pradana Soewondo,Sidartawan Soegondo,Ketut Suastika,Agung Pranoto,Djoko Wahono Soeatmadji,Askandar Tjokroprawiro +5 more
TL;DR: Information on diabetes management, diabetes complications, and awareness of self-control in diabetic population of the country, and the physician perspectives, psychological aspects, and quality of life of diabetic patients is collected.
Book ChapterDOI
Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases
TL;DR: Age is an Important Risk Factor for Type 2 Diabetes Mellitus and Cardiovascular Diseases.
Journal ArticleDOI
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
Antonia Anna Lukito,Raymond Pranata,Joshua Henrina,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: Preliminary findings showed that mortality was lowered in those who consume metformin vs who did not, and given its low cost and widespread availability, met formin is an attractive and potential regimen for mitigating excessive risk in diabetic populations.